Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEG for Aspirin and Clopidogrel Resistance in STEMI
NCT00697021Phase 3Unknown
- Sponsor
- Shamir Medical Center
- Start
- Jun 2008
- Primary completion
- Jun 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label trial of clopidogrel and aspirin in myocardial infarction (MI), sponsored by Shamir Medical Center. Status: unknown.
02
Drugs
clopidogrelaspirin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00697021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00697021.